Related content

Economic Analyses of Toxicity Secondary to Anthracycline-based Breast Cancer Chemotherapy

By Dranitsaris G.   Tran T.M.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2174-2180

Elsevier

Access to resources Recommend Favorite

Clinical and economic impact of epoetin in adjuvant-chemotherapy for breast cancer

By Fagnoni Philippe   Limat Samuel   Chaigneau Loïc   Guardiola Emmanuel   Briaud Stéphanie   Schmitt Bernard   Merrouche Yacine   Pivot Xavier   Woronoff-Lemsi Marie-Christine  

Supportive Care in Cancer, Vol. 14, Iss. 10, 2006-10 ,pp. : 1030-1037

Springer Publishing Company

Access to resources Recommend Favorite

The Swedish Council on Technology Assessment in Health Care (SBU) Report on Cancer Chemotherapy - Project Objectives, the Working Process, Key Definitions and General Aspects on Cancer Trial Methodology and Interpretation

By Nygren Peter   Glimelius Bengt  

Acta Oncologica, Vol. 40, Iss. 2-3, 2001-03 ,pp. : 155-165

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy and Antiangiogenesis

By Lennernäs Bo   Albertsson Per   Lennernäs Hans   Norrby Klas  

Acta Oncologica, Vol. 42, Iss. 4, 2003-01 ,pp. : 294-303

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy and Other

By  

Sarcoma, Vol. 6, Iss. 1, 2002-05 ,pp. : 29-37

Informa Healthcare

Access to resources Recommend Favorite